ABSTRACT
Cannabinoids, the bioactive constituents of the marijuana plant and their synthetic and endogenous analogs cause not only neurobehavioral, but also cardiovascular effects. The most important component of these effects is a profound decrease in blood pressure and heart rate. Although multiple lines of evidence indicate that the hypotensive and bradycardic effects of anandamide and other cannabinoids are mediated by peripherally located CB1 cannabinoid receptors, anandamide can also elicit vasodilation in certain vascular beds, which is independent of CB1 or CB2 receptors. Possible cellular mechanisms underlying these effects and the cellular sources of vasoactive anandamide are discussed.
Subject(s)
Cannabinoids/pharmacology , Cardiovascular System/drug effects , Arachidonic Acids/pharmacology , Cannabinoid Receptor Modulators , Cannabis , Endocannabinoids , Polyunsaturated Alkamides , Vasodilation/drug effectsABSTRACT
Interferons (IFNs) have been used in the treatment of viral hepatitis. However, their effectiveness is much reduced (<10%) in alcoholics. The mechanism underlying this resistance remains unknown. Here, we report that IFN-alpha/beta and IFN-gamma rapidly activate the JAK-STAT1 (Janus kinase-signal transducer and activator transcription factor 1) and p42/44 mitogen-activated protein kinase (p42/44 MAPK) in freshly isolated rat hepatocytes. Treatment of hepatocytes with 25-100 mM ethanol for 30 min inhibited IFN-beta- or IFN-gamma-induced STAT1 activation and tyrosine phosphorylation. The inhibitory effect of ethanol was not reversed by pretreatment with either sodium vanadate, a non-selective tyrosine phosphatase inhibitor, or with MG132, a specific proteasome inhibitor. This suggests that protein tyrosine phosphatases or the ubiquitin-proteasome pathway are not involved in the inhibitory action of ethanol. In contrast with the JAK-STAT signalling pathway, acute ethanol exposure significantly potentiated IFN-beta or IFN-gamma-induced activation of p42/44 MAPK, and caused marked activation of protein kinase C (PKC). Inhibition of PKC partially antagonized ethanol attenuation of IFN-induced STAT1 activation, suggesting that PKC may be involved. Taken together, these findings suggest that the ability of biologically relevant concentrations of ethanol (less than 100 mM) to markedly inhibit IFN-activated STAT1 is one of the cellular mechanisms responsible for the observed resistance of IFN therapy in alcoholics.
Subject(s)
Ethanol/pharmacology , Hepatocytes/drug effects , Interferons/pharmacology , JNK Mitogen-Activated Protein Kinases , Mitogen-Activated Protein Kinase 1/metabolism , Mitogen-Activated Protein Kinases/metabolism , Protein Kinase C/metabolism , Protein Serine-Threonine Kinases , Signal Transduction/physiology , Animals , Cells, Cultured , Cysteine Endopeptidases/metabolism , DNA-Binding Proteins/metabolism , Drug Interactions , Drug Synergism , Enzyme Activation , Hepatocytes/enzymology , Hepatocytes/metabolism , Interferon-alpha/pharmacology , Interferon-beta/pharmacology , Interferon-gamma/pharmacology , Janus Kinase 1 , MAP Kinase Kinase 4 , Mitogen-Activated Protein Kinase 3 , Mitogen-Activated Protein Kinase Kinases/metabolism , Multienzyme Complexes/metabolism , Phosphorylation , Proteasome Endopeptidase Complex , Protein Tyrosine Phosphatases/metabolism , Protein-Tyrosine Kinases/metabolism , Proto-Oncogene Proteins/metabolism , Proto-Oncogene Proteins c-akt , Rats , STAT1 Transcription Factor , Trans-Activators/metabolism , Tyrosine/metabolism , Ubiquitins/metabolismABSTRACT
To understand the mechanisms by which ethanol inhibits hepatocyte proliferation, we studied the effects of ethanol on p42/44 mitogen-activated protein kinase (MAPK), p38 mitogen-activated protein kinase (p38 MAPK) and c-Jun N-terminal kinase (JNK) in normal and regenerating rat liver. Treatment of rat hepatocytes with 100 mM ethanol in vitro for 16 h prolonged the activation of p42/44 MAPK and p38 MAPK induced by various agonists. Such treatment also increased basal JNK activity, but did not potentiate or prolong agonist-induced JNK activation. Ethanol potentiation of the activation of p42/44 MAPK was abolished by pertussis toxin. In contrast, chronic ethanol consumption in vivo inhibited the activation of p42/44 MAPK, p38 MAPK and JNK induced either by partial hepatectomy or by various agonists. However, both acute and chronic ethanol inhibited hepatocyte proliferation induced by insulin and epidermal growth factor. A selective inhibitor of p42/44 MAPK partially prevented the inhibition of hepatocyte proliferation caused by acute, but not by chronic, ethanol exposure, whereas a selective inhibitor of p38 MAPK further inhibited hepatocyte proliferation under both conditions. These data suggest that acute and chronic ethanol inhibit hepatocyte proliferation by different mechanisms. The effect of acute ethanol may be related to the prolongation of p42/44 MAPK activation, whereas inhibition of hepatocyte proliferation by chronic ethanol may be due to inhibition of p38 MAPK activation.
Subject(s)
Calcium-Calmodulin-Dependent Protein Kinases/metabolism , Ethanol/toxicity , Liver Regeneration/drug effects , Liver Regeneration/physiology , Liver/drug effects , Liver/enzymology , Mitogen-Activated Protein Kinases , Alcoholism/enzymology , Alcoholism/pathology , Animals , Cell Division/drug effects , Enzyme Activation/drug effects , GTP-Binding Proteins/metabolism , Hepatectomy , JNK Mitogen-Activated Protein Kinases , Liver/cytology , Male , Mitogen-Activated Protein Kinase 1/metabolism , Mitogen-Activated Protein Kinase 3 , Pertussis Toxin , Rats , Rats, Sprague-Dawley , Virulence Factors, Bordetella/pharmacology , p38 Mitogen-Activated Protein KinasesABSTRACT
To study the mechanisms by which catecholamines regulate hepatocyte proliferation after partial hepatectomy (PHX), hepatocytes were isolated from adult male rats 24 h after sham operation or two-thirds PHX and treated with catecholamines and other agonists. In freshly isolated sham cells, p42 mitogen-activated protein (MAP) kinase activity was stimulated by the alpha1-adrenergic agonist phenylephrine (PHE). Activation of p42 MAP kinase by growth factors was blunted by pretreatment of sham hepatocytes with glucagon but not by that with the beta2-adrenergic agonist isoproterenol (ISO). In PHX cells, the ability of PHE to activate p42 MAP kinase was dramatically reduced, whereas ISO became competent to inhibit p42 MAP kinase activation. PHE treatment of sham but not PHX and ISO treatment of PHX but not sham hepatocytes also activated the stress-activated protein (SAP) kinases p46/54 SAP kinase and p38 SAP kinase. These data demonstrate that an alpha1- to beta2-adrenergic receptor switch occurs upon PHX and results in an increase in SAP kinase versus MAP kinase signaling by catecholamines. In primary cultures of hepatocytes, ISO treatment of PHX but not sham cells inhibited [3H]thymidine incorporation. In contrast, PHE treatment of sham but not PHX cells stimulated [3H]thymidine incorporation, which was reduced by approximately 25 and approximately 95% with specific inhibitors of p42 MAP kinase and p38 SAP kinase function, respectively. Inhibition of the p38 SAP kinase also dramatically reduced basal [3H]thymidine incorporation. These data suggest that p38 SAP kinase plays a permissive role in liver regeneration. Alterations in the abilities of catecholamines to modulate the activities of protein kinase A and the MAP and SAP kinase pathways may represent one physiological mechanism by which these agonists can regulate hepatocyte proliferation after PHX.
Subject(s)
Adrenergic Agonists/pharmacology , Calcium-Calmodulin-Dependent Protein Kinases/physiology , Liver Regeneration , Liver/physiology , Mitogen-Activated Protein Kinases , Receptors, Adrenergic, alpha-1/physiology , Receptors, Adrenergic, beta-2/physiology , Stress, Physiological/physiopathology , Animals , Cell Division , Cyclic AMP-Dependent Protein Kinases/physiology , JNK Mitogen-Activated Protein Kinases , Liver/cytology , Male , Phosphorylases/metabolism , Protein Serine-Threonine Kinases/physiology , Proto-Oncogene Proteins/physiology , Proto-Oncogene Proteins c-raf , Rats , Rats, Sprague-Dawley , Time Factors , p38 Mitogen-Activated Protein KinasesABSTRACT
1. Activation of CB1 receptors by plant cannabinoids or the endogenous ligand, anandamide, causes hypotension via a sympathoinhibitory action in anaesthetized rats. In mouse isolated vas deferens, activation of CB1 receptors inhibits the electrically evoked twitch response. To determine if these effects are related to presynaptic inhibition of noradrenaline (NA) release, we examined the effects of delta 9-tetrahydrocannabinol (delta 9-THC), anandamide and the CB1 antagonist, SR141716A, on exocytotic NA release in rat isolated atria and vasa deferentia. 2. In isolated atria and vasa deferentia preloaded with [3H]-NA, electrical field stimulation caused [3H]-NA release, which was abolished by tetrodotoxin 0.5 microM and concentration-dependently inhibited by delta 9-THC or anandamide, 0.3-10 microM. The inhibitory effect of delta 9-THC and anandamide was competitively antagonized by SR 141716A, 1-10 microM. 3. Tyramine, 1 microM, also induced [3H]-NA release, which was unaffected by tetrodotoxin, delta 9-THC or anandamide in either atria or vasa deferentia. 4. CB1 receptor mRNA is present in the superior cervical ganglion, as well as in whole brain, cerebellum, hypothalamus, spleen, and vas deferens and absent in medulla oblongata and atria, as demonstrated by reverse transcription-polymerase chain reaction. There was no evidence of the presence of CB1A receptor mRNA in ganglia, brain, or cerebellum. These results suggest that activation of presynaptic CB1 receptors located on peripheral sympathetic nerve terminals mediate sympathoinhibitory effects in vitro and in vivo.
Subject(s)
Norepinephrine/metabolism , Peripheral Nervous System/drug effects , Presynaptic Terminals/drug effects , Receptors, Drug/drug effects , Sympathetic Nervous System/drug effects , Animals , Arachidonic Acids/pharmacology , Calcium Channel Blockers/pharmacology , Dose-Response Relationship, Drug , Endocannabinoids , Male , Polyunsaturated Alkamides , Rats , Rats, Sprague-Dawley , Receptors, CannabinoidSubject(s)
Liver/physiology , Receptors, Adrenergic, alpha/physiology , Receptors, Adrenergic, beta/physiology , Animals , Gene Expression Regulation , Liver Glycogen/metabolism , Liver Regeneration , Male , Phorbol Esters/pharmacology , Promoter Regions, Genetic , Protein Kinase C/physiology , RNA, Messenger/genetics , Rats , Rats, Sprague-Dawley , Signal Transduction , Transcription, GeneticABSTRACT
In vitro incubation of hepatocytes acutely isolated from adult male rats leads to a rapid conversion of the adrenergic activation of glycogenolysis from an alpha 1-receptor (alpha 1AR) to a beta 2-receptor (beta 2AR) mediated response within 4 h. In order to understand the underlying mechanism, we examined time-dependent changes in alpha 1- and beta 2-adrenergic activation of glycogenolysis and second messenger systems, the cellular density and affinity of alpha 1AR and beta 2AR, and the steady state levels of alpha 1BAR and beta 2AR mRNAs. Incubation of hepatocytes for 4 h resulted in a decrease in phosphorylase activation and inositol 1,4,5 trisphosphate accumulation in response to phenylephrine, a 40% decrease in alpha 1AR density, and a 70% decrease in alpha 1BAR mRNA levels. Incubation of hepatocytes for 4 h also resulted in the emergence of a phosphorylase response to isoproterenol, an increase in isoproterenol-induced but not in glucagon- or forskolin-induced cAMP accumulation, no significant change in beta 2AR density, and a twofold increase in beta 2AR mRNA levels. Exposure of cells to cycloheximide, 2 microM throughout the 4 h incubation, prevented the emergence of the phosphorylase response to isoproterenol and reduced beta 2AR densities, while the decrease in alpha 1AR density was not affected and the decrease in phosphorylase activation by phenylephrine was attenuated. The results indicate that dissociation of rat liver cells triggers a rapidly developing decrease in alpha 1BAR mRNA and increase in beta 2AR mRNA levels and corresponding inverse changes in the synthesis of alpha 1BAR and beta 2AR which account, at least in part, for the rapid conversion from alpha 1- to beta 2-adrenergic glycogenolysis.
Subject(s)
Liver/cytology , Receptors, Adrenergic, alpha/genetics , Receptors, Adrenergic, beta/genetics , Transcription, Genetic/genetics , Animals , Cells, Cultured , Colforsin/metabolism , Cyclic AMP/metabolism , Cycloheximide/pharmacology , Glucagon/metabolism , Inositol 1,4,5-Trisphosphate/metabolism , Isoproterenol/pharmacology , Liver/metabolism , Liver/ultrastructure , Male , Phenylephrine/pharmacology , RNA, Messenger/analysis , RNA, Messenger/genetics , Rats , Rats, Inbred Strains , Receptors, Adrenergic, alpha/analysis , Receptors, Adrenergic, alpha/metabolism , Receptors, Adrenergic, beta/analysis , Receptors, Adrenergic, beta/metabolism , Time FactorsABSTRACT
Steady state levels of the mRNAs for alpha 1B, beta 1- and beta 2-adrenergic receptors (alpha 1BAR, beta 1AR, beta 2AR) were quantified by DNA excess solution hybridization assays in the heart, lungs, and liver of rats. Tissues for RNA extraction were obtained from euthyroid and thyroidectomized rats and from thyroidectomized rats treated with a single dose of thyroxine. Thyroidectomy resulted in significant decreases in beta 1AR and beta 2AR mRNAs in heart and lung and alpha 1BAR mRNA in liver, whereas the levels of beta 2AR mRNA in liver and alpha 1BAR mRNA in heart and lung were significantly increased. All these changes were reversed within 20 hours of a single s.c. injection of 1 mg/kg thyroxine. These findings indicate for the first time that thyroid state regulates mRNA levels for adrenergic receptors, and that this regulation is tissue- and receptor-specific. The changes in adrenergic receptor mRNAs correlate with and probably underlie the well documented, thyroid-dependent changes in the cellular densities and physiological reactivities of adrenergic receptors.
Subject(s)
Gene Expression Regulation , Hypothyroidism/metabolism , RNA, Messenger/metabolism , Receptors, Adrenergic, alpha/genetics , Receptors, Adrenergic, beta/genetics , Animals , Gene Expression Regulation/drug effects , Liver/metabolism , Lung/metabolism , Male , Myocardium/metabolism , Nucleic Acid Hybridization , Organ Specificity , Rats , Rats, Inbred Strains , Thyroidectomy , Thyroxine/pharmacologyABSTRACT
The fatty acid composition of total lipids and the adrenoceptor-mediated activation of glycogenolysis were studied in isolated hepatocytes from rats maintained on a control diet or on an essential fatty acid (EFA)-free diet. In cells from rats on the EFA-free diet there was a marked reduction in linoleic and arachidonic acid (AA) contents and an increase in eicosatrienoic, oleic, and palmitoleic acid contents compared to controls. In freshly isolated cells from both groups, phosphorylase a activity was increased by phenylephrine or epinephrine but not by isoproterenol, and the effect of epinephrine was inhibited by phenoxybenzamine but not by propranolol. When control cells were preincubated in a serum-free buffer for 4 h before testing, the effect of phenylephrine on phosphorylase a activity was reduced, isoproterenol became a potent agonist and the effect of epinephrine was partially inhibited either by phenoxybenzamine or by propranolol. The emerging beta-adrenergic response in 4-h cells was associated with a marked potentiation of isoproterenol-induced cAMP accumulation. A similar 4-h preincubation of EFA-deficient cells resulted in a reduced response to phenylephrine while isoproterenol remained ineffective for increasing either phosphorylase a activity or cAMP production. The response of these 4-h cells to isoproterenol could be restored by in vivo replacement of the EFA-deficient diet with control diet for the last 4 weeks prior to the experiment, but not by the in vitro exposure of the EFA-deficient cells to 10 microM AA throughout the 4-h incubation period. Extending previous observations (Refs. (6-8)), the present results suggest that the time-dependent emergence of beta-adrenergic glycogenolysis, but not the parallel reduction of the alpha-adrenergic response, is mediated by AA or its metabolite(s), which probably act by facilitating the G-protein-dependent coupling of beta-receptors.
Subject(s)
Epinephrine/pharmacology , Fatty Acids, Essential/deficiency , Isoproterenol/pharmacology , Liver Glycogen/metabolism , Liver/metabolism , Phenylephrine/pharmacology , Receptors, Adrenergic/physiology , Animals , Cells, Cultured , Colforsin/pharmacology , Cyclic AMP/metabolism , Fatty Acids, Unsaturated/isolation & purification , Fatty Acids, Unsaturated/metabolism , Female , Glucagon/pharmacology , Kinetics , Liver/drug effects , Melitten/pharmacology , Phosphorylase a/metabolism , Pregnancy , Rats , Rats, Inbred Strains , Receptors, Adrenergic/drug effects , Reference ValuesABSTRACT
1. The release of radioactivity from rat isolated atria preloaded with [3H]-noradrenaline ([3H]-NA) evoked by electrical field stimulation (2 Hz, 1 ms, 60 s) of intraneuronal sympathetic nerves, high potassium (64.7 mM) or tyramine (0.3 micron) was used as an index of noradrenaline release. 2. Activation of protein kinase C by phorbol 12-myristate 13-acetate (PMA) produced a concentration-dependent enhancement of field stimulation-induced outflow of radioactivity, whereas polymyxin B, an inhibitor of protein kinase C, reduced [3H]-NA release evoked by field stimulation. The enhancement observed in the presence of PMA was attenuated by polymyxin B (10 and 70 microns). 3. Release of noradrenaline evoked by membrane depolarization in a high potassium medium was similarly affected by PMA and polymyxin B. 4. In contrast, the release of noradrenaline evoked by the indirectly acting sympathomimetic amine, tyramine, was not altered by PMA. Polymyxin B in a concentration of 70 microns, but not 10 microns caused a slight reduction in tyramine-induced outflow of radioactivity. 5. The spontaneous outflow of radioactive compounds was not affected by either PMA or polymyxin B in the bathing medium. 6. The findings suggest that protein kinase C may play a role in the exocytotic release of noradrenaline but not in the displacement of noradrenaline by indirectly acting sympathomimetic amines.
Subject(s)
Norepinephrine/metabolism , Protein Kinase C/physiology , Tetradecanoylphorbol Acetate/pharmacology , Animals , Electric Stimulation , Enzyme Activation/drug effects , Exocytosis/drug effects , Heart/innervation , In Vitro Techniques , Male , Polymyxin B/pharmacology , Potassium/pharmacology , Protein Kinase C/antagonists & inhibitors , Rats , Rats, Inbred Strains , Tetrodotoxin/pharmacology , Tyramine/pharmacologyABSTRACT
1. Incubation of isolated rat liver cells in a serum-free buffer leads to the reduction of the glycogenolytic effect of phenylephrine and the simultaneous emergence of the response to isoprenaline within 4 h. 2. Inhibitors of phospholipase A2 reverse the adrenergic activation of phosphorylase alpha from a beta- to an alpha 1-receptor-mediated event. Conversely activators of phospholipase A2 enhance the conversion. 3. In vitro incubation of hepatocytes leads to a translocation of protein kinase C from the cytosol to the membrane which can be mimicked by phorbol 12-myristate 13-acetate (PMA), an activator of protein kinase C. PMA is also associated with transformation from alpha 1- to beta-adrenoceptor-mediated glycogenolysis. 4. It is proposed that coupling of hepatic alpha 1- and beta-adrenoceptors to postreceptor pathways are regulated by changes in membrane phospholipase A2 and protein kinase C activity.
Subject(s)
Liver Glycogen/metabolism , Liver/metabolism , Receptors, Adrenergic, alpha/physiology , Receptors, Adrenergic, beta/physiology , Animals , Cells, Cultured , Phospholipases A/physiology , Phospholipases A2 , Protein Kinase C/physiology , Rats , Time FactorsABSTRACT
In conscious, chronically cannulated, unrestrained rats, systemic administration of catecholamines increases the plasma levels of beta-endorphin-like immunoreactivity (beta Ei). In euthyroid rats, this effect is mediated by both alpha 1 and beta-adrenergic receptors; the rise in plasma beta Ei caused by isoproterenol is blocked by 1 mg/kg propranolol, and the similar effects of norepinephrine and phenylephrine are blocked by 0.1 mg/kg prazosin. Both types of responses are completely suppressed by a 4-h pretreatment of rats with 0.1 mg/kg dexamethasone, indicating the anterior pituitary origin of the beta Ei released. Prior sectioning of the pituitary stalk does not significantly reduce the response to either phenylephrine or isoproterenol, suggesting that both agents act directly on the pituitary. Hypothyroidism induced by surgical thyroidectomy does not influence the beta Ei response to isoproterenol, which remains sensitive to block by propranolol or suppression by dexamethasone. However, neither norepinephrine nor phenylephrine is able to increase plasma beta Ei in the hypothyroid animals. Both isoproterenol and phenylephrine remain fully effective in rats made hyperthyroid by daily injections of 40 micrograms/kg T3 for 4 days. We propose that in unstressed rats catecholamines increase plasma beta Ei by a direct action on the anterior pituitary via either alpha 1- or beta-adrenergic receptors, and that expression of the alpha 1-, but not the beta-adrenergic response is regulated by thyroid hormones.
Subject(s)
Endorphins/metabolism , Isoproterenol/pharmacology , Norepinephrine/pharmacology , Phenylephrine/pharmacology , Pituitary Gland, Anterior/metabolism , Prazosin/pharmacology , Propranolol/pharmacology , Thyroid Gland/physiology , Thyroidectomy , Animals , Dexamethasone/pharmacology , Endorphins/blood , Male , Pituitary Gland, Anterior/drug effects , Rats , Rats, Inbred Strains , beta-EndorphinABSTRACT
Intravenous administration to pithed Wistar rats of the angiotensin converting enzyme inhibitor enalapril (0.1-1.0 mg/kg) lowered the diastolic blood pressure and reduced pressor responses occurring during electrical stimulation (1-30 Hz) of the spinal sympathetic outflow. These doses of enalapril given intravenously also attenuated pressor responses to intravenous injection of the muscarinic ganglion stimulant McNeil-A-343 (50, 100, 150 micrograms/kg) and noradrenaline (0.1-5.0 micrograms/kg). Enalapril (1.0 mg/kg, i.v.) reduced pressor responses to the nicotinic ganglion stimulant 1,1-dimethyl-4-phenyl-piperazinium (300 micrograms/kg, i.v.). These results confirmed that the actions of enalapril resemble those of captopril in the pithed rat, by causing reductions in both blood pressure and pressor responses to sympathetic stimuli.
Subject(s)
Blood Pressure/drug effects , Enalapril/pharmacology , Sympathetic Nervous System/physiology , (4-(m-Chlorophenylcarbamoyloxy)-2-butynyl)trimethylammonium Chloride/pharmacology , Animals , Decerebrate State , Dimethylphenylpiperazinium Iodide/antagonists & inhibitors , Electric Stimulation , Male , Norepinephrine/antagonists & inhibitors , Rats , Rats, Inbred Strains , Sympathetic Nervous System/drug effectsABSTRACT
In vitro incubation of isolated rat liver cells in a serum-free buffer leads to the suppression of the glycogenolytic effect of phenylephrine and the simultaneous emergence of a glycogenolytic response to isoproterenol within 4 hr. This time-dependent conversion of the adrenergic receptor response from alpha 1 to beta type is prevented by the presence in the incubation medium of 0.5% fatty-acid-free, but not regular, bovine serum albumin. A 20-min exposure of freshly isolated liver cells to arachidonic acid (10 micrograms/ml), but not to stearic or palmitic acid, causes an acute shift in the receptor response from alpha 1 to mixed alpha 1/beta type, similar in direction to that seen after prolonged incubation of the cells. This effect of arachidonic acid is prevented by 0.2 microM ibuprofen but not by the same concentration of nordihydroguaiaretic acid. Ibuprofen (1 microM) or indomethacin (1 microM) also inhibits the time-dependent shift in the receptor response. Actinomycin D inhibits the change in receptor response that is caused by prolonged incubation but not the change that is caused by exogenous arachidonic acid. It is proposed that the time-dependent conversion from alpha 1- to beta-adrenergic receptor-mediated glycogenolysis in isolated rat liver cells is related to a parallel increase in the phospholipase-mediated release of arachidonic acid and the subsequent formation of a key cyclooxygenase metabolite. A protein factor appears to be involved in the regulation of the release of arachidonic acid but not in the action of its metabolite. A possible mechanism by which this metabolite may regulate inverse changes in the coupling of alpha 1- and beta-receptors to postreceptor pathways is discussed.
Subject(s)
Arachidonic Acids/pharmacology , Glycogen/metabolism , Liver/metabolism , Receptors, Adrenergic, alpha/metabolism , Receptors, Adrenergic, beta/metabolism , Animals , Arachidonic Acid , Arachidonic Acids/metabolism , Catechols/pharmacology , Dactinomycin/pharmacology , Epinephrine/pharmacology , Fatty Acids/metabolism , Ibuprofen/pharmacology , Isoproterenol/pharmacology , Liver/drug effects , Male , Masoprocol , Phenylephrine/pharmacology , Phospholipases A/metabolism , Prazosin/pharmacology , Propranolol/pharmacology , Rats , Rats, Inbred Strains , Receptors, Adrenergic, alpha/drug effects , Receptors, Adrenergic, beta/drug effectsABSTRACT
Many physiologic and pathologic conditions, including bronchial asthma, are associated with inverse changes in alpha- and beta-receptor-mediated responses in various tissues. The direction of the change elicited by a given stimulus is tissue specific, as exemplified by the actions of thyroid hormones: In the rat heart, hypothyroidism reduces beta- and increases alpha-receptor responses, whereas in the rat liver it has the opposite effects. A similar increase in beta- and decrease in alpha-receptor responses in the rat liver is triggered by a number of different conditions, including glucocorticoid deficiency, that appear to represent lower levels of cellular differentiation. Among these, incubation of isolated hepatocytes in a serum-free buffer triggers the conversion of the receptor response in vitro within 4 hours, without parallel changes in the density or affinity of receptor binding sites. This change can be acutely reversed by an endogenous inhibitor of membrane phospholipase A2, or accelerated by an activator of phospholipase A2, suggesting that changes in the activity of this enzyme are involved in the conversion of the hepatic adrenoceptor response. The glucocorticoid-induced increase in beta-receptors in cultured human lung adenocarcinoma cells also appears to be mediated indirectly through the induction of an endogenous inhibitor (lipomodulin) of membrane phospholipase A2. The possible relevance of altered membrane phospholipid metabolism in the pathomechanism of asthma and in the associated glucocorticoid-sensitive changes in adrenergic receptor mechanisms is discussed.
Subject(s)
Receptors, Adrenergic, alpha/physiology , Receptors, Adrenergic, beta/physiology , Animals , Asthma/physiopathology , Glucocorticoids/physiology , Humans , Liver/physiology , Liver Glycogen/metabolism , Phospholipases A/physiology , Phospholipases A2 , Rats , Thyroid Gland/physiologyABSTRACT
The adrenergic activation of glycogenolysis in the rat liver is converted from an alpha-1 to a beta-2-receptor mediated event in various conditions associated with cellular dedifferentiation. Short-term incubation of isolated hepatocytes in a serum-free medium results in a similar conversion of the adrenoceptor response, without concomitant changes in the density or affinity of alpha-1 or beta-receptor binding sites. This time-dependent conversion can be prevented or reversed by inhibitors of protein synthesis, by an endogenous inhibitor of phospholipase A2 (lipomodulin), or by removal of fatty acids from the medium through a lipid-trap. Conversely, activation of phospholipase A2 or addition of exogenous arachidonic acid to freshly isolated rat liver cells induces an acute conversion from alpha-1 to beta-type response, and the effect of the latter is prevented by the cyclooxygenase inhibitor, ibuprofen. It is proposed that reciprocal changes in alpha-1 and beta-2 receptor activity in rat liver cells are triggered by inverse changes in the coupling of the two receptors to their respective post-receptor pathways. These changes are mediated by a cyclooxygenase product generated through increased phospholipase A2 activity.
Subject(s)
Liver/metabolism , Receptors, Adrenergic, alpha/metabolism , Animals , Catecholamines/metabolism , Humans , Liver/cytology , Liver Glycogen/metabolism , Phenotype , Phospholipases A/metabolism , Phospholipases A2 , Time FactorsABSTRACT
Reciprocal changes in alpha- and beta-receptor responses occur in a number of in vivo as well as in vitro conditions. Incubation of isolated rat liver cells in a serum-free buffer results in the conversion of the adrenergic activation of glycogenolysis from an alpha 1 to a beta-receptor mediated response within 4 h. The decrease in the alpha 1-adrenergic response and the simultaneous emergence of a beta-adrenergic response are selective with regards to the effects of other glycogenolytic hormones and are not accompanied by changes in the density or affinity of alpha 1 or beta-receptor binding sites. Lipomodulin, an endogenous inhibitor of membrane phospholipase A2, reverses the receptor response in 4 h cells from beta to alpha, whereas lipomodulin antibody, or melittin, a phospholipase A2 activator, have opposite effects in freshly isolated cells. The time-dependent conversion of the adrenoceptor response is prevented by the presence of indomethacin or inhibitors of protein or mRNA synthesis, and is accelerated by a serine protease inhibitor. These findings are interpreted to indicate that changes in membrane phospholipase A2 activity are involved in the conversion of the adrenergic receptor response in isolated rat liver cells, by influencing the coupling of alpha 1 and beta-receptors to postreceptor pathways in an inverse, reciprocal manner. The activation of this mechanism requires a protein factor(s), whose cellular levels are controlled by a balance between protein synthetic and proteolytic activities. The possibility that this phospholipase effect is mediated by a cyclooxygenase product is under study.
Subject(s)
Calcium-Binding Proteins , Liver/metabolism , Receptors, Adrenergic, alpha/metabolism , Receptors, Adrenergic, beta/metabolism , 5,8,11,14-Eicosatetraynoic Acid/pharmacology , Animals , Annexins , Cells, Cultured , Cycloheximide/pharmacology , Dactinomycin/pharmacology , Glucagon/pharmacology , Glycoproteins/pharmacology , Isoproterenol/pharmacology , Kinetics , Liver Glycogen/metabolism , Male , Phenylephrine/pharmacology , Phospholipases A/metabolism , Phospholipases A2 , Rats , Vasopressins/pharmacologyABSTRACT
Incubation of isolated rat liver cells in a serum-free buffer leads to the reduction of the glycogenolytic effect of phenylephrine and the simultaneous emergence of a glycogenolytic response to isoproterenol within 4 hr. This conversion of the adrenergic activation of phosphorylase from an alpha 1- to a beta-adrenoceptor-mediated response is associated with no change in the glycogenolytic response to the calcium-linked activator vasopressin, and a reduction of the glycogenolytic response to the cAMP-linked activator glucagon. In vitro incubation of hepatocytes does not influence the density of affinity of [3H]prazosin-labeled alpha 1-receptors and [3H]CGP-12177-labeled beta-receptors. In cells preincubated for 4 hr, a further 30-min incubation with 50 nM lipomodulin, an endogenous inhibitor of membrane phospholipase A2 (EC 3.1.1.4), reverses the adrenergic activation of phosphorylase from a beta- to an alpha 1-receptor-mediated event, whereas in freshly isolated cells lipomodulin does not affect the predominant alpha-receptor response. Conversely, exposure of freshly isolated cells to a monoclonal antibody to lipomodulin in the presence of 10 microM phenylephrine, or to melittin, an activator of phospholipase A2, at 2 micrograms/ml, results in the suppression of the effect of phenylephrine and the emergence of a response to isoproterenol within 30 min. It is proposed that coupling of hepatic alpha 1- and beta-adrenoceptors to postreceptor pathways is regulated in an inverse reciprocal manner by changes in membrane phospholipase A2 activity.
Subject(s)
Liver Glycogen/metabolism , Liver/metabolism , Phospholipases A/metabolism , Phospholipases/metabolism , Receptors, Adrenergic, alpha/physiology , Receptors, Adrenergic, beta/physiology , Animals , Cell Membrane/enzymology , Glucagon/pharmacology , In Vitro Techniques , Isoproterenol/pharmacology , Kinetics , Liver/drug effects , Male , Phenylephrine/pharmacology , Phospholipases A2 , Rats , Rats, Inbred Strains , Vasopressins/pharmacologyABSTRACT
Rats were treated with methimazole or thyroxine to render them either hypothyroid or hyperthyroid. Left atria from these animals and from control, untreated rats were isolated, placed in organ baths, and paced by direct electrical stimulation delivered via a punctate electrode. Contractile responses to trains of stimuli at 0.01-6 Hz were recorded isometrically. Atria from methimazole-treated rats required less voltage to elicit submaximal contractions; these were greater in magnitude and duration than those recorded from control preparations. The reverse was observed for preparations from hyperthyroid rats. Thyroid state had a marked influence upon the pattern of contractions elicited by trains of stimuli at varying frequencies. Atria from control rats displayed a typical negative interval-strength relationship, i.e., a decrease in contractile amplitude as the interval between stimuli in a train was decreased. This negative relationship was more pronounced in left atria from hypothyroid rats. In preparations from hyperthyroid rats, increases in stimulation frequency resulted in elevations in contractile amplitude. These observations are discussed in the light of known actions of thyroid hormone upon cardiac contractile mechanisms.